$GNSS
Genasys Inc. Stock $gnss

$gnss Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-Q Financial Statement

#000143774924004092 Filed on February 14, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2022 Q4
Revenue	$5.739M	$4.361M	$10.49M
YoY Change	-48.82%	-58.42%	-1.78%
Cost Of Revenue	$3.562M	$2.882M	$5.944M
YoY Change	-43.35%	-51.51%	2.78%
Gross Profit	$2.177M	$1.479M	$4.543M
YoY Change	-55.8%	-67.44%	-7.17%
Gross Profit Margin	37.93%	33.91%	43.32%
Selling, General & Admin	$6.640M	$6.518M	$6.095M
YoY Change	9.68%	6.94%	18.72%
% of Gross Profit	305.01%	440.7%	134.16%
Research & Development	$2.531M	$2.191M	$1.935M
YoY Change	10.96%	13.23%	41.34%
% of Gross Profit	116.26%	148.14%	42.59%
Depreciation & Amortization	$731.0K	$729.0K	$643.0K
YoY Change	14.4%	13.37%	0.63%
% of Gross Profit	33.58%	49.29%	14.15%
Operating Expenses	$9.171M	$8.709M	$8.030M
YoY Change	10.03%	8.46%	23.48%
Operating Profit	-$6.994M	-$7.230M	-$3.487M
YoY Change	105.1%	107.34%	116.72%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net	$51.00K	$77.00K	-$20.00K
YoY Change	240.0%	-485.0%	-253.85%
Pretax Income	-$6.943M	-$7.153M	-$3.507M
YoY Change	104.51%	103.96%	119.74%
Income Tax	-$5.000K	-$429.0K	$0.00
% Of Pretax Income
Net Earnings	-$6.938M	-$6.724M	-$3.507M
YoY Change	103.88%	91.73%	168.74%
Net Earnings / Revenue	-120.89%	-154.18%	-33.44%
Basic Earnings Per Share	-$0.16	-$0.15	-$0.10
Diluted Earnings Per Share	-$0.16	-$0.15	-$0.10
COMMON SHARES
Basic Shares Outstanding	44.03M	44.03M	36.70M
Diluted Shares Outstanding	44.25M	43.73M	36.70M

Balance Sheet

Concept	2024 Q1	2023 Q4	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.544M	$4.780M	$7.563M
YoY Change	-44.37%	-36.8%	-42.56%
Cash & Equivalents	$3.544M	$4.780M	$7.563M
Short-Term Investments	$0.00	$0.00	$0.00
Other Short-Term Assets	$251.0K	$342.0K	$184.0K
YoY Change	-2.71%	85.87%	44.88%
Inventory	$6.564M	$6.890M	$8.003M
Prepaid Expenses
Receivables	$2.820M	$4.435M	$3.297M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$22.26M	$26.98M	$29.09M
YoY Change	-18.41%	-7.24%	-7.65%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.483M	$1.587M	$1.755M
YoY Change	-12.97%	-9.57%	-3.62%
Goodwill	$13.25M	$13.15M	$10.31M
YoY Change	28.08%	27.58%	-56.67%
Intangibles	$9.743M	$10.37M	$10.00M
YoY Change	2.74%	3.62%	-18.34%
Long-Term Investments			$1.034M
YoY Change			-69.42%
Other Assets	$785.0K	$840.0K	$7.891M
YoY Change	-90.19%	-89.35%	-19.9%
Total Long-Term Assets	$28.77M	$29.66M	$35.38M
YoY Change	-16.41%	-16.17%	-36.58%
TOTAL ASSETS
Total Short-Term Assets	$22.26M	$26.98M	$29.09M
Total Long-Term Assets	$28.77M	$29.66M	$35.38M
Total Assets	$51.03M	$56.64M	$64.46M
YoY Change	-17.29%	-12.14%	-26.14%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.597M	$1.897M	$2.609M
YoY Change	-26.05%	-27.29%	15.49%
Accrued Expenses	$8.308M	$8.618M	$8.075M
YoY Change	11.62%	6.72%	-35.97%
Deferred Revenue	$4.638M	$4.213M	$4.596M
YoY Change	32.25%	-8.33%	-52.45%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$11.93M	$11.55M	$11.64M
YoY Change	-0.05%	-0.79%	-27.56%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$445.0K	$509.0K	$243.0K
YoY Change	179.87%	109.47%	-75.58%
Total Long-Term Liabilities	$445.0K	$509.0K	$243.0K
YoY Change	179.87%	109.47%	-75.58%
TOTAL LIABILITIES
Total Short-Term Liabilities	$11.93M	$11.55M	$11.64M
Total Long-Term Liabilities	$445.0K	$509.0K	$243.0K
Total Liabilities	$16.15M	$16.09M	$16.86M
YoY Change	-4.44%	-4.6%	-25.23%
SHAREHOLDERS EQUITY
Retained Earnings	-$89.72M	-$82.79M	-$60.87M
YoY Change	39.59%	36.0%	43.37%
Common Stock	$0.00	$0.00	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$34.88M	$40.55M	$47.60M
YoY Change
Total Liabilities & Shareholders Equity	$51.03M	$56.64M	$64.46M
YoY Change	-17.29%	-12.14%	-26.14%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2022 Q4
OPERATING ACTIVITIES
Net Income	-$6.938M	-$6.724M	-$3.507M
YoY Change	103.88%	91.73%	168.74%
Depreciation, Depletion And Amortization	$731.0K	$729.0K	$643.0K
YoY Change	14.4%	13.37%	0.63%
Cash From Operating Activities	-$6.767M	-$5.729M	-$4.850M
YoY Change	158.68%	18.12%	79.5%
INVESTING ACTIVITIES
Capital Expenditures	$11.00K	$142.0K	$98.00K
YoY Change	-81.36%	44.9%	-38.36%
Acquisitions		$923.0K	$0.00
YoY Change
Other Investing Activities	$5.778M	-$8.208M	-$385.0K
YoY Change	295.75%	2031.95%	-266.67%
Cash From Investing Activities	$5.767M	-$9.114M	-$483.0K
YoY Change	311.63%	1786.96%	-770.83%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-231.0K	$10.45M	$32.00K
YoY Change	-2666.67%	32553.13%	-108.1%
NET CHANGE
Cash From Operating Activities	-6.767M	-$5.729M	-$4.850M
Cash From Investing Activities	5.767M	-$9.114M	-$483.0K
Cash From Financing Activities	-231.0K	$10.45M	$32.00K
Net Change In Cash	-1.231M	-$4.393M	-$5.262M
YoY Change	2.07%	-16.51%	73.32%
FREE CASH FLOW
Cash From Operating Activities	-$6.767M	-$5.729M	-$4.850M
Capital Expenditures	$11.00K	$142.0K	$98.00K
Free Cash Flow	-$6.778M	-$5.871M	-$4.948M
YoY Change	153.38%	18.65%	72.95%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	11259000	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4283000	usd
CY2023Q3	us-gaap	Liabilities Liabilities	16093000	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	44027121
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	2785000	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	7466000	usd
CY2023Q3	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	96000	usd
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	11546000	usd
CY2023Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	551000	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	0	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	123725000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-82786000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-386000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	40553000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	56638000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4780000	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8665000	usd
CY2023Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	8777000	usd
CY2023Q3	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	1481000	usd
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	0	usd
CY2023Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent	758000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	65000	usd
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	65000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4435000	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5952000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	6890000	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	6501000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2100000	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1851000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	26982000	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	25208000	usd
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q4	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2025
CY2023Q4	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--09-30
CY2023Q4	dei	Amendment Flag AmendmentFlag	false
CY2023Q4	dei	Entity Central Index Key EntityCentralIndexKey	0000924383
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	pure
CY2023Q4	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0
CY2022Q4	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0
CY2023Q4	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
CY2023	us-gaap	Dividends Dividends	0	usd
CY2023Q4	us-gaap	Dividends Dividends	0	usd
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod	P7Y
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2022Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022Q4	us-gaap	Short Term Lease Cost ShortTermLeaseCost	0	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	0	usd
CY2023	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	usd
CY2023Q3	us-gaap	Marketable Securities MarketableSecurities	0	usd
CY2023Q4	us-gaap	Marketable Securities MarketableSecurities	0	usd
CY2023Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	0	usd
CY2023Q3	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	0	usd
CY2023Q4	gnss	Number Of Additional Inactive Subsidiaries NumberOfAdditionalInactiveSubsidiaries	2	pure
CY2023Q4	gnss	Number Of Wholly Owned Subsidiaries NumberOfWhollyOwnedSubsidiaries	9	pure
CY2023Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2023Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	346000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1587000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1551000	usd
CY2023Q4	us-gaap	Goodwill Gross GoodwillGross	13151000	usd
CY2023Q3	us-gaap	Goodwill Gross GoodwillGross	10282000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	10366000	usd
CY2023Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	8427000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3712000	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3886000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	494000	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	455000	usd
CY2023Q4	us-gaap	Assets Assets	56638000	usd
CY2023Q3	us-gaap	Assets Assets	49905000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1897000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8618000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1031000	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1008000	usd
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2023Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	44027121
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	37211071
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	37211071
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	0	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	110379000	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-76062000	usd
CY2023Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-505000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	33812000	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	49905000	usd
CY2023Q4	us-gaap	Cost Of Revenue CostOfRevenue	2882000	usd
CY2023Q4	us-gaap	Gross Profit GrossProfit	1479000	usd
CY2022Q4	us-gaap	Gross Profit GrossProfit	4832000	usd
CY2023Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	6518000	usd
CY2022Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	6384000	usd
CY2023Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2191000	usd
CY2022Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1935000	usd
CY2023Q4	us-gaap	Operating Expenses OperatingExpenses	8709000	usd
CY2022Q4	us-gaap	Operating Expenses OperatingExpenses	8319000	usd
CY2023Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-7230000	usd
CY2022Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-3487000	usd
CY2023Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	77000	usd
CY2022Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-20000	usd
CY2023Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-7153000	usd
CY2022Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3507000	usd
CY2023Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-429000	usd
CY2022Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	-6724000	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-3507000	usd
CY2023Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.15
CY2022Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.1
CY2023Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	43729240
CY2022Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	36696145
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	-6724000	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-3507000	usd
CY2023Q4	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	10000	usd
CY2022Q4	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	21000	usd
CY2023Q4	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	109000	usd
CY2022Q4	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	245000	usd
CY2023Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-6605000	usd
CY2022Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3241000	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-3507000	usd
CY2023Q4	us-gaap	Depreciation And Amortization DepreciationAndAmortization	729000	usd
CY2022Q4	us-gaap	Depreciation And Amortization DepreciationAndAmortization	643000	usd
CY2023Q4	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	0	usd
CY2022Q4	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	5000	usd
CY2023Q4	gnss	Product Warranty Expense Benefit ProductWarrantyExpenseBenefit	-22000	usd
CY2022Q4	gnss	Product Warranty Expense Benefit ProductWarrantyExpenseBenefit	24000	usd
CY2023Q4	us-gaap	Inventory Write Down InventoryWriteDown	39000	usd
CY2022Q4	us-gaap	Inventory Write Down InventoryWriteDown	46000	usd
CY2023Q4	gnss	Gain Loss On Disposition Of Fixed Assets GainLossOnDispositionOfFixedAssets	-2000	usd
CY2022Q4	gnss	Gain Loss On Disposition Of Fixed Assets GainLossOnDispositionOfFixedAssets	-0	usd
CY2023Q4	us-gaap	Share Based Compensation ShareBasedCompensation	446000	usd
CY2022Q4	us-gaap	Share Based Compensation ShareBasedCompensation	420000	usd
CY2023Q4	gnss	Partial Release Of Valuation Allowance PartialReleaseOfValuationAllowance	517000	usd
CY2022Q4	gnss	Partial Release Of Valuation Allowance PartialReleaseOfValuationAllowance	-0	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	192000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	199000	usd
CY2023Q4	us-gaap	Accretion Expense AccretionExpense	5000	usd
CY2022Q4	us-gaap	Accretion Expense AccretionExpense	12000	usd
CY2023Q4	gnss	Accretion Of Acquisition Contingent Consideration AccretionOfAcquisitionContingentConsideration	46000	usd
CY2022Q4	gnss	Accretion Of Acquisition Contingent Consideration AccretionOfAcquisitionContingentConsideration	0	usd
CY2023Q4	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1666000	usd
CY2022Q4	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-3482000	usd
CY2023Q4	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	429000	usd
CY2022Q4	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2041000	usd
CY2023Q4	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	249000	usd
CY2022Q4	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-624000	usd
CY2023Q4	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-902000	usd
CY2022Q4	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	249000	usd
CY2023Q4	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-11000	usd
CY2022Q4	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-5006000	usd
CY2023Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5729000	usd
CY2022Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4850000	usd
CY2023Q4	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	7532000	usd
CY2022Q4	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	1994000	usd
CY2023Q4	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	247000	usd
CY2022Q4	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	1609000	usd
CY2023Q4	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	923000	usd
CY2022Q4	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	-0	usd
CY2023Q4	gnss	Payments To Acquire Asset Purchase Holdback Liability PaymentsToAcquireAssetPurchaseHoldbackLiability	764000	usd
CY2022Q4	gnss	Payments To Acquire Asset Purchase Holdback Liability PaymentsToAcquireAssetPurchaseHoldbackLiability	-0	usd
CY2023Q4	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	142000	usd
CY2022Q4	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	98000	usd
CY2023Q4	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-9114000	usd
CY2022Q4	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-483000	usd
CY2023Q4	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
CY2022Q4	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	32000	usd
CY2023Q4	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	10449000	usd
CY2022Q4	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
CY2023Q4	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	10449000	usd
CY2022Q4	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	32000	usd
CY2023Q4	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1000	usd
CY2022Q4	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	39000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-4393000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-5262000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	9519000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	13659000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5126000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8397000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4780000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7563000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	0	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	738000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	346000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	96000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5126000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8397000	usd
CY2023Q4	gnss	Noncash Or Part Noncash Unrealized Loss On Marketable Securities NoncashOrPartNoncashUnrealizedLossOnMarketableSecurities	10000	usd
CY2022Q4	gnss	Noncash Or Part Noncash Unrealized Loss On Marketable Securities NoncashOrPartNoncashUnrealizedLossOnMarketableSecurities	21000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	4213000	usd
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	4722000	usd
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	4213000	usd
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.89	pure
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P12M
CY2023Q4	us-gaap	Nature Of Operations NatureOfOperations	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>1. OPERATIONS </b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 27pt;">Genasys Inc. is a global provider of Protective Communications™ solutions including its Genasys Protect™ software platform and Genasys Long Range Acoustic Devices® (“LRAD®”). The Company's unified platform receives information from a wide variety of sensors and Internet-of-Things (“IoT”) inputs to collect real-time information on developing and active emergency situations. The Company uses this information to create and disseminate alerts, warnings, notifications, and instructions through multiple channels before, during, and after public safety and enterprise threats, critical events, and other crisis situations.</p>
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4780000	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8665000	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	346000	usd
CY2023Q3	us-gaap	Restricted Cash RestrictedCash	854000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	65000	usd
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	65000	usd
CY2023Q4	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i><span style="text-decoration: underline; ">Reclassifications</span></i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 27pt;">Where necessary, certain prior year’s information has been reclassified to conform to the current year presentation.</p>
CY2023Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	4020000	usd
CY2023Q4	gnss	Contract With Customer Liability Increase For New Contract ContractWithCustomerLiabilityIncreaseForNewContract	2402000	usd
CY2023Q4	gnss	Contract With Customer Liability Revenue Recognized During Period ContractWithCustomerLiabilityRevenueRecognizedDuringPeriod	1705000	usd
CY2023Q4	gnss	Contract With Customer Liability Effect Of Exchange Rate ContractWithCustomerLiabilityEffectOfExchangeRate	5000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	4722000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	509000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	1060000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	3510000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	3000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	132000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	2000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	3642000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	5000	usd
CY2023Q3	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	684000	usd
CY2023Q3	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	2000	usd
CY2023Q3	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	496000	usd
CY2023Q3	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	8000	usd
CY2023Q3	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	1180000	usd
CY2023Q3	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	10000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5372000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5325000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3785000	usd
CY2023Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3774000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1587000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1551000	usd
CY2023Q4	us-gaap	Goodwill Gross GoodwillGross	13151000	usd
CY2023Q3	us-gaap	Goodwill Gross GoodwillGross	10282000	usd
CY2023Q3	us-gaap	Goodwill Goodwill	10282000	usd
CY2023Q4	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	2772000	usd
CY2023Q4	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	97000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	13151000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	8427000	usd
CY2023Q4	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	2550000	usd
CY2023Q4	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	619000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Foreign Currency Translation Gain Loss FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss	8000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	10366000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	17239000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	14620000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	6873000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	6193000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	10366000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	8427000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	1861000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	2358000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	2222000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	2048000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1220000	usd
CY2023Q4	gnss	Finitelived Intangible Asset Expected Amortization After Year Four FinitelivedIntangibleAssetExpectedAmortizationAfterYearFour	657000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	10366000	usd
CY2023Q4	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	619000	usd
CY2023Q3	gnss	Deposits For Inventory DepositsForInventory	301000	usd
CY2023Q3	us-gaap	Prepaid Insurance PrepaidInsurance	264000	usd
CY2023Q3	gnss	Due And Subscription DueAndSubscription	261000	usd
CY2023Q3	gnss	Prepaid Professional Services PrepaidProfessionalServices	136000	usd
CY2023Q3	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	417000	usd
CY2023Q4	gnss	Prepaid Trade Shows And Travel PrepaidTradeShowsAndTravel	93000	usd
CY2023Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	114000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	342000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2100000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2104000	usd
CY2023Q4	gnss	Accrued Contract Costs AccruedContractCosts	897000	usd
CY2023Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	110000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	123000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8618000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	509000	usd
CY2023Q3	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	132000	usd
CY2023Q4	gnss	Product Warranty Accrual Increase Decrease For New Warranties Issuance And Adjustment Preexisting Warranties ProductWarrantyAccrualIncreaseDecreaseForNewWarrantiesIssuanceAndAdjustmentPreexistingWarranties	-22000	usd
CY2023Q4	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	-0	usd
CY2023Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	110000	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3886000	usd
CY2023Q4	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	192000	usd
CY2023Q4	gnss	Effect Of Exchange Rate On Operating Lease Rou Assets EffectOfExchangeRateOnOperatingLeaseROUAssets	18000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3712000	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	5291000	usd
CY2023Q4	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2023Q4	us-gaap	Operating Lease Payments OperatingLeasePayments	248000	usd
CY2023Q4	gnss	Effect Of Exchange Rate On Operating Lease Liability EffectOfExchangeRateOnOperatingLeaseLiability	18000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	5061000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4030000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1031000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	909000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1186000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1200000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1221000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1047000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	0	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	5563000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	502000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	5061000	usd
CY2023Q4	us-gaap	Operating Lease Expense OperatingLeaseExpense	245000	usd
CY2023Q4	us-gaap	Short Term Lease Cost ShortTermLeaseCost	5000	usd
CY2023Q4	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.06	pure
CY2022Q4	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2023Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-429000	usd
CY2023Q4	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	517000	usd
CY2023Q4	us-gaap	Increase Decrease In Other Employee Related Liabilities IncreaseDecreaseInOtherEmployeeRelatedLiabilities	40000	usd
CY2022Q4	us-gaap	Increase Decrease In Other Employee Related Liabilities IncreaseDecreaseInOtherEmployeeRelatedLiabilities	548000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	6449196
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	887250
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.578	rate
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.521	rate
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.043	rate
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.041	rate
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	rate
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	rate
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y2M12D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y1M6D
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	2154000	usd
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y4M24D
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2904522
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.19
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	887250
CY2023Q4	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.7
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	25000
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	1.7
CY2023Q4	gnss	Share Based Compensation Arrangement By Share Based Payment Award Options Gross Exercises In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrossExercisesInPeriod	-0
CY2023Q4	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3766772
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.85
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	992981
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	3.48
CY2023Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit	1.51
CY2023Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit	8.03
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y6M
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	322000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	29000	usd
CY2023Q4	us-gaap	Share Price SharePrice	2.03
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	0	usd
CY2023Q4	gnss	Gross Proceeds From Stock Options Exercised GrossProceedsFromStockOptionsExercised	0	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	23000	usd
CY2022Q4	gnss	Gross Proceeds From Stock Options Exercised GrossProceedsFromStockOptionsExercised	32000	usd
CY2023Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	3766772
CY2023Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P5Y5M26D
CY2023Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	2.85
CY2023Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	992981
CY2023Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	3.48
CY2023Q4	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	446000	usd
CY2022Q4	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	420000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	33812000	usd
CY2023Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	446000	usd
CY2023Q4	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	10449000	usd
CY2023Q4	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2023Q4	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	1924000	usd
CY2023Q4	gnss	Increase In Additional Paidin Capital Obligation To Issue Common Stock IncreaseInAdditionalPaidinCapitalObligationToIssueCommonStock	527000	usd
CY2023Q4	gnss	Stock Released From Obligation To Issue Value StockReleasedFromObligationToIssueValue	0	usd
CY2023Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	119000	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	-6724000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	40553000	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	50393000	usd
CY2021Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	420000	usd
CY2021Q4	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	32000	usd
CY2021Q4	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2021Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	266000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	47604000	usd
CY2023Q4	us-gaap	Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures	10000
CY2022Q4	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	20000
CY2022Q4	gnss	Gross Proceeds From Stock Options Exercised GrossProceedsFromStockOptionsExercised	32000	usd
CY2022Q4	us-gaap	Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures	12667
CY2023Q4	gnss	Underwritten Public Offering Common Stock UnderwrittenPublicOfferingCommonStock	5750000
CY2023Q4	gnss	Price Per Share Underwritten Agreement PricePerShareUnderwrittenAgreement	2
CY2023Q4	gnss	Gross Proceeds From Underwritten Public Offering Common Stock GrossProceedsFromUnderwrittenPublicOfferingCommonStock	11500000	usd
CY2023Q4	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	1051000	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	-6724000	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-3507000	usd
CY2023Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.15
CY2022Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.1
CY2023Q4	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	43729240
CY2022Q4	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	36696145
CY2023Q4	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0
CY2022Q4	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0
CY2023Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	43729240
CY2022Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	36696145
CY2023Q4	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4146369
CY2022Q4	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5224275
CY2023Q4	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	4361000	usd
CY2022Q4	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	10487000	usd
CY2023Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-7230000	usd
CY2022Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-3487000	usd
CY2023Q4	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	729000	usd
CY2022Q4	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	643000	usd
CY2023Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-429000	usd
CY2022Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q4	us-gaap	Noncurrent Assets NoncurrentAssets	11953000	usd
CY2023Q3	us-gaap	Noncurrent Assets NoncurrentAssets	9978000	usd
CY2023Q4	us-gaap	Assets Assets	56638000	usd
CY2023Q3	us-gaap	Assets Assets	49905000	usd
CY2023Q4	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	4361000	usd
CY2022Q4	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	10487000	usd
CY2023Q4	us-gaap	Noncurrent Assets NoncurrentAssets	11953000	usd
CY2023Q3	us-gaap	Noncurrent Assets NoncurrentAssets	9978000	usd

Files In Submission

Name	View Source	Status
0001437749-24-004092-index-headers.html	Edgar Link	pending
0001437749-24-004092-index.html	Edgar Link	pending
0001437749-24-004092.txt	Edgar Link	pending
0001437749-24-004092-xbrl.zip	Edgar Link	pending
ex_623834.htm	Edgar Link	pending
ex_623835.htm	Edgar Link	pending
ex_623836.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
gnss-20231231.xsd	Edgar Link	pending
gnss20231231_10q.htm	Edgar Link	pending
gnss20231231_10qimg001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
gnss-20231231_cal.xml	Edgar Link	unprocessable
gnss-20231231_lab.xml	Edgar Link	unprocessable
gnss-20231231_pre.xml	Edgar Link	unprocessable
gnss20231231_10q_htm.xml	Edgar Link	completed
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
gnss-20231231_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$GNSS
Genasys Inc. Stock $gnss

2024 Q1 Form 10-Q Financial Statement

#000143774924004092 Filed on February 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GNSS Genasys Inc. Stock $gnss

2024 Q1 Form 10-Q Financial Statement

#000143774924004092 Filed on February 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GNSS
Genasys Inc. Stock $gnss